The Legal Battle Over the Abortion Pill
More than half of abortions in the U.S. are medication abortions -- a two-pill regimen that is used to terminate pregnancies through 10 weeks of gestation. Mifepristone is also used off-label to help patients experiencing miscarriages or stillbirths expel pregnancy tissue and avoid procedures.
But federal court rulings have raised questions about the future availability of mifepristone, which was approved by the Food and Drug Administration 23 years ago, and the FDA's future ability to approve and regulate medicines.
Managing Editor Lori Robertson and Science Editor Jessica McDonald answer some of those questions in "Q&A on the Medication Abortion Court Rulings."
Lori and Jess explain the legal and health issues raised by the lawsuit, which was brought by four anti-abortion organizations and four physicians. They explain how mifepristone works when combined with misoprostol, when it was approved and its history of regulation.
They also answer questions such as: "How safe and effective is mifepristone?" As they write, 22 clinical trials, including seven in the U.S., have evaluated mifepristone when used with misoprostol at 10 weeks or less of gestation. The results show patients have a complete medical abortion at least 96.2% of the time, meaning the drug fails in less than 4% of cases.
Jess interviewed the senior author of one of those papers -- a paper cited by the District Court judge's ruling in Texas -- who told her that the research shows an "impressive safety" record of "medical abortion, even if provided via telemedicine.”
The Q&A also tackles what's next in the legal battle.
|